DK0462182T3 - Matrixmetalloproteinasepeptider: Rolle ved diagnose og behandling - Google Patents

Matrixmetalloproteinasepeptider: Rolle ved diagnose og behandling

Info

Publication number
DK0462182T3
DK0462182T3 DK90904575.9T DK90904575T DK0462182T3 DK 0462182 T3 DK0462182 T3 DK 0462182T3 DK 90904575 T DK90904575 T DK 90904575T DK 0462182 T3 DK0462182 T3 DK 0462182T3
Authority
DK
Denmark
Prior art keywords
peptides
enzyme
inhibitors
metalloproteinase
metalloproteinases
Prior art date
Application number
DK90904575.9T
Other languages
Danish (da)
English (en)
Inventor
Lance A Liotta
William Stetler-Stevenson
Henry C Krutzsch
Original Assignee
Us Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/317,407 external-priority patent/US5270447A/en
Application filed by Us Health filed Critical Us Health
Application granted granted Critical
Publication of DK0462182T3 publication Critical patent/DK0462182T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/8146—Metalloprotease (E.C. 3.4.24) inhibitors, e.g. tissue inhibitor of metallo proteinase, TIMP
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
DK90904575.9T 1989-03-01 1990-03-01 Matrixmetalloproteinasepeptider: Rolle ved diagnose og behandling DK0462182T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/317,407 US5270447A (en) 1988-05-20 1989-03-01 Metalloproteinase peptides: role in diagnosis and therapy
US07/488,460 US5280106A (en) 1988-05-20 1990-02-26 Matrix metalloproteinase peptides: role in diagnosis and therapy

Publications (1)

Publication Number Publication Date
DK0462182T3 true DK0462182T3 (da) 1996-06-10

Family

ID=26980933

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90904575.9T DK0462182T3 (da) 1989-03-01 1990-03-01 Matrixmetalloproteinasepeptider: Rolle ved diagnose og behandling

Country Status (9)

Country Link
US (3) US5280106A (de)
EP (1) EP0462182B1 (de)
JP (3) JP2736821B2 (de)
AT (1) ATE138076T1 (de)
AU (1) AU635007B2 (de)
DE (1) DE69027024T2 (de)
DK (1) DK0462182T3 (de)
ES (1) ES2088426T3 (de)
WO (1) WO1990010228A1 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5280106A (en) * 1988-05-20 1994-01-18 Liotta Lance A Matrix metalloproteinase peptides: role in diagnosis and therapy
CA2074945A1 (en) * 1990-11-30 1992-05-31 Atsushi Isoai Tumor cell invasion-inhibiting peptides, peptide complexes and cancer metastasis inhibitors
US5837686A (en) * 1991-11-25 1998-11-17 Peptide Therapeutics Limited Peptides and antibodies for treatment of rheumatoid arthritis
AU3968193A (en) * 1992-03-26 1993-10-21 Gensia, Inc. In vivo peptide therapy
EP0639982A1 (de) * 1992-05-01 1995-03-01 British Biotech Pharmaceuticals Limited Verwendung von mmp hemmer
EP1262493A1 (de) * 1992-10-29 2002-12-04 Bayer Corporation Diagnostischer Test spezifisch für die latente Matrix Metalloproteinase no. 9
US5829174A (en) * 1994-04-08 1998-11-03 Sno-Way International, Inc. Articulated snowplow system
FI98961C (fi) * 1994-08-26 1997-09-10 Medix Biochemica Ab Oy Menetelmät ja määritysvälineet parodontaalisairauden aktiivisuuden ja/tai peri-implantiitin ja/tai niiden kohonneen riskin diagnosoimiseksi
US5759864A (en) * 1995-06-23 1998-06-02 Cedars Sinai Medical Center Methods for reducing background binding in antibody preparations
US6811995B1 (en) 1996-04-26 2004-11-02 Children's Medical Center Corporation Non-invasive enzyme screen for cancer
US6037138A (en) * 1996-04-26 2000-03-14 The Children's Medical Center Corp. Enzyme screen for breast cancer
AU775537B2 (en) * 1996-04-26 2004-08-05 Children's Medical Center Corporation Non-invasive enzyme screen for tissue remodelling-associated conditions
US5990293A (en) * 1996-09-05 1999-11-23 Celltech Therapeutics Limited Human metalloproteinase, variants thereof and DNA sequence coding therefor
AUPO573697A0 (en) * 1997-03-20 1997-04-10 Prince Henry's Institute Of Medical Research Diagnosis of endometrial cancer
WO1999065519A1 (en) * 1998-06-16 1999-12-23 The General Hospital Corporation Matrix metalloproteinase proenzyme activator
US20020151481A1 (en) * 2000-04-27 2002-10-17 Lawrence Weissbach MMP-2 propeptide for use as antiangiogenic or antitumor agent
US6767537B2 (en) 2000-05-26 2004-07-27 Phil Arnold Nicolay Composition and method for the treatment of sinusitis
US6600057B2 (en) 2000-12-29 2003-07-29 Kimberly-Clark Worldwide, Inc. Matrix metalloproteinase inhibitors
US7041787B2 (en) * 2000-12-29 2006-05-09 Kimberly-Clark Worldwide, Inc. Design and use of advanced zinc chelating peptides to regulate matrix metalloproteinases
US7094754B2 (en) * 2001-08-16 2006-08-22 Kimberly-Clark Worldwide, Inc. Anti-aging and wound healing compounds
US6906036B2 (en) * 2001-08-16 2005-06-14 Kimberly-Clark Worldwide, Inc. Anti-aging and wound healing compounds
US7186693B2 (en) 2001-08-16 2007-03-06 Kimberly - Clark Worldwide, Inc. Metalloproteinase inhibitors for wound healing
US7071164B2 (en) * 2001-08-16 2006-07-04 Kimberly-Clark Worldwide, Inc. Anti-cancer and wound healing compounds
US20030119073A1 (en) * 2001-12-21 2003-06-26 Stephen Quirk Sensors and methods of detection for proteinase enzymes
EE200400030A (et) 2002-01-23 2004-04-15 Rath Matthias Sünteetiline oligopeptiid, selle kasutamine maatriksmetalloproteinaasi aktiivsuse pärssimiseks ningvähkkasvaja invasiooni ja metastaaside ärahoidmiseks ja ravimiseks
US7148194B2 (en) * 2002-12-30 2006-12-12 Kimberly-Clark Worldwide, Inc. Method to increase fibronectin
US7189700B2 (en) * 2003-06-20 2007-03-13 Kimberly-Clark Worldwide, Inc. Anti-chrondrosarcoma compounds
US7405037B2 (en) * 2004-05-07 2008-07-29 Lonza Walkersville, Inc. Methods and tools for detecting collagen degradation
LT5328B (lt) 2004-08-23 2006-03-27 Matthias Rath Sintetiniai peptidai ir jų panaudojimas vėžio invazijos ir metastazių gydymui ir profilaktikai
US9078727B2 (en) 2006-03-16 2015-07-14 Boston Scientific Scimed, Inc. System and method for treating tissue wall prolapse
US20070286813A1 (en) * 2006-06-09 2007-12-13 Toutounghi Camille Nasal formulation
KR101166387B1 (ko) 2007-03-17 2012-07-23 삼성전자주식회사 공기조화기의 실외기
US8481477B2 (en) 2010-01-12 2013-07-09 New York University Methods, agents and peptides for inducing an immune response to matrix metalloproteinase-2 expressing tumors
KR102504844B1 (ko) * 2019-02-01 2023-03-02 울산과학기술원 엔도트로핀 절단 효소의 저해제를 포함하는 엔도트로핀 활성 저해용 조성물 및 이의 용도

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4486530A (en) * 1980-08-04 1984-12-04 Hybritech Incorporated Immunometric assays using monoclonal antibodies
US4677058A (en) * 1983-05-19 1987-06-30 Karl Tryggvason Detecting malignant cells with monoclonal antibodies specific to type IV collagenase enzyme
US4923818A (en) * 1987-09-04 1990-05-08 Washington University DNA clone of human type IV collagenase
US5280106A (en) * 1988-05-20 1994-01-18 Liotta Lance A Matrix metalloproteinase peptides: role in diagnosis and therapy

Also Published As

Publication number Publication date
ES2088426T3 (es) 1996-08-16
EP0462182A4 (en) 1992-08-12
US5585356A (en) 1996-12-17
JP2001011093A (ja) 2001-01-16
JP2736821B2 (ja) 1998-04-02
AU5184090A (en) 1990-09-26
US5280106A (en) 1994-01-18
JPH04501423A (ja) 1992-03-12
DE69027024D1 (de) 1996-06-20
WO1990010228A1 (en) 1990-09-07
AU635007B2 (en) 1993-03-11
JP3252283B2 (ja) 2002-02-04
JPH09249700A (ja) 1997-09-22
EP0462182B1 (de) 1996-05-15
US5372809A (en) 1994-12-13
DE69027024T2 (de) 1997-01-09
EP0462182A1 (de) 1991-12-27
ATE138076T1 (de) 1996-06-15

Similar Documents

Publication Publication Date Title
EP0462182A4 (en) Matrix metalloproteinase peptides: role in diagnosis and therapy
Hotez et al. Isolation and characterization of a proteolytic enzyme from the adult hookworm Ancylostoma caninum.
Netzel-Arnett et al. Sequence specificities of human fibroblast and neutrophil collagenases.
Lowe The cysteine proteinases
Mehdi Cell-penetrating inhibitors of calpain
Harris Jr et al. An endopeptidase from rheumatoid synovial tissue culture
Dunn Determination of protease
Ma et al. PA28, an activator of the 20 S proteasome, is inactivated by proteolytic modification at its carboxyl terminus.
ES8800050A1 (es) Un procedimiento para la preparacion de derivados de cetona electrofilicos activados de sustratos de peptidasa, utiles en la inhibicion de enzimas proteasas
Senten et al. Development of potent and selective dipeptidyl peptidase II inhibitors
HIRAO et al. Purification and characterization of cathepsin B from monkey skeletal muscle
CN113164557A (zh) 治疗神经性病症的方法
ES2106772T3 (es) Variantes de pai-2.
Moore et al. Peptide hydroxamic acids inhibit skin collagenase
JPH02147954A (ja) ヒトの血清または血漿におけるオステオカルシンの決定法
Weng et al. The covalent structure of bovine liver rhodanese. NH2-terminal sequence and partial structural analysis of tryptic peptides from the citraconylated protein.
Tu Local Tissue Oamaging (Hemorrhage and Myonecrosis) Toxins from Rattlcsnake and Other Pit Viper Venoms
CA2050343A1 (en) Matrix metalloproteinase peptides: role in diagnosis and therapy
Tanizawa et al. Inverse substrates for trypsin and trypsin-like enzymes
Itoh et al. Flow injection analysis for measurement of activity of matrix metalloproteinase-7 (MMP-7)
Small Serum acetylcholinesterase possesses trypsin-like and carboxypeptidase B-like activity
Nguyen et al. Specific and irreversible cyclopeptide inhibitors of dipeptidyl peptidase IV activity of the T-cell activation antigen CD26
Guinec et al. Quantitative study of the binding of cysteine proteinases to basement membranes
DE69502095D1 (de) Festphasenimmunoassay zum nachweis von inhibitoren von einem proteolytischen enzym
Cowgill Fluorescence and the structure of proteins VIII. Iodination of ribonuclease modified by subtilisin